Jordá J - Search Results

1

A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.

Cuní S, Pérez-Aciego P, Pérez-Chacón G, Vargas JA, Sánchez A, Martín-Saavedra FM, Ballester S, García-Marco J, Jordá J, Durántez A. Cuní S, et al. Among authors: jorda j. Leukemia. 2004 Aug;18(8):1391-400. doi: 10.1038/sj.leu.2403398. Leukemia. 2004. PMID: 15175625

2

Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.

Pérez-Chacón G, Contreras-Martín B, Cuní S, Rosado S, Martín-Donaire T, Losada-Fernández I, Vargas JA, Jordá J, Alvarez N, García-Marco J, Pérez-Aciego P. Pérez-Chacón G, et al. Among authors: jorda j. Am J Clin Pathol. 2005 May;123(5):646-50. Am J Clin Pathol. 2005. PMID: 15981803

3

CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.

Perez-Chacon G, Vargas JA, Jorda J, Morado M, Rosado S, Martin-Donaire T, Losada-Fernandez I, Rebolleda N, Perez-Aciego P. Perez-Chacon G, et al. Among authors: jorda j. Leuk Res. 2007 Feb;31(2):183-93. doi: 10.1016/j.leukres.2006.03.021. Epub 2006 May 24. Leuk Res. 2007. PMID: 16725198

4

CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.

Perez-Chacon G, Vargas JA, Jorda J, Alvarez N, Martin-Donaire T, Rosado S, Losada-Fernandez I, Rebolleda N, Perez-Aciego P. Perez-Chacon G, et al. Among authors: jorda j. Leuk Lymphoma. 2007 Jan;48(1):147-57. doi: 10.1080/10428190600989331. Leuk Lymphoma. 2007. PMID: 17325858

5

Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia.

Perez-Chacon G, Rosado S, Rebolleda N, Losada-Fernandez I, Vargas JA, Morado M, Jorda J, Perez-Aciego P. Perez-Chacon G, et al. Among authors: jorda j. Int J Lab Hematol. 2009 Jun;31(3):327-37. doi: 10.1111/j.1751-553X.2008.01030.x. Epub 2008 Feb 3. Int J Lab Hematol. 2009. PMID: 18241213

6

Heterogeneous proliferative effect of tumor necrosis factor-alpha and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemia.

Alvarez-Mon M, Garcia-Suarez J, Prieto A, Manzano L, Reyes E, Lorences C, Peraile G, Jorda J, Durantez A. Alvarez-Mon M, et al. Among authors: jorda j. Am J Hematol. 1993 Jun;43(2):81-5. doi: 10.1002/ajh.2830430202. Am J Hematol. 1993. PMID: 8342555

7

Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor.

Alvarez-Mon M, de la Hera A, Gaspar ML, Orfao A, Casas J, Jordá J, Durantez A. Alvarez-Mon M, et al. Among authors: jorda j. Acta Haematol. 1989;81(2):91-7. doi: 10.1159/000205533. Acta Haematol. 1989. PMID: 2496557

8

Clinical signification of natural killer activity in B-cell chronic lymphocytic leukemia.

Alvarez-Mon M, Casas J, Laguna R, Jordá J, Durantez A. Alvarez-Mon M, et al. Among authors: jorda j. Eur J Haematol. 1987 Mar;38(3):268-73. doi: 10.1111/j.1600-0609.1987.tb01175.x. Eur J Haematol. 1987. PMID: 3496239

9

[Diagnostic importance of the mouse erythrocyte receptor in lymphoproliferative syndromes].

Laguna R, Alvarez de Mon M, Casas J, Jordá J, Durántez A. Laguna R, et al. Among authors: jorda j. Rev Clin Esp. 1987 Jun;181(1):4-6. Rev Clin Esp. 1987. PMID: 3498190 Spanish. No abstract available.

10

Diminished natural killer activity in pregnancy: modulation by interleukin 2 and interferon gamma.

Vaquer S, de la Hera A, Jordá J, Martínez C, Escudero M, Alvarez-Mon M. Vaquer S, et al. Among authors: jorda j. Scand J Immunol. 1987 Dec;26(6):691-8. doi: 10.1111/j.1365-3083.1987.tb02305.x. Scand J Immunol. 1987. PMID: 3122313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters